Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.830
-0.120 (-6.15%)
At close: Oct 10, 2025, 4:00 PM EDT
1.820
-0.010 (-0.55%)
After-hours: Oct 10, 2025, 7:58 PM EDT

Cognition Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-32.99-33.97-25.79-21.4-11.72-7.84
Depreciation & Amortization
0.250.270.250.240.090.1
Stock-Based Compensation
2.643.754.353.575.180.48
Other Adjustments
-0.20.32--0.030.77
Change in Receivables
-3.19-1.412.39-1.41-1.113
Changes in Accounts Payable
1.051.852.44-0.752.17-0.36
Changes in Accrued Expenses
----1.270.6
Changes in Unearned Revenue
0.53-0.64-1.692.640.5-
Changes in Other Operating Activities
0.991.471.7-1.420.02-0.17
Operating Cash Flow
-30.73-28.47-16.02-18.53-3.63-3.43
Capital Expenditures
--0-0.15-0.17-0.03-0.01
Investing Cash Flow
--0-0.15-0.17-0.03-0.01
Short-Term Debt Issued
-----0.44
Net Short-Term Debt Issued (Repaid)
-----0.44
Long-Term Debt Issued
-----5.37
Long-Term Debt Repaid
-0.62-0.74-0.81-1.4-0.27-0
Net Long-Term Debt Issued (Repaid)
-0.62-0.74-0.81-1.4-0.275.37
Issuance of Common Stock
14.4124.435.336.9453.470.05
Repurchase of Common Stock
--0.13----
Net Common Stock Issued (Repurchased)
14.4124.35.336.9453.470.05
Other Financing Activities
------0.09
Financing Cash Flow
13.7623.574.525.5553.25.77
Effect of Exchange Rate Changes on Cash and Cash Equivalents
--0-0-0.01-0.02
Net Cash Flow
-16.98-4.91-11.64-13.1649.532.3
Beginning Cash & Cash Equivalents
28.5329.9241.5654.725.192.89
Ending Cash & Cash Equivalents
11.5625.0129.9241.5654.725.19
Free Cash Flow
-30.73-28.48-16.17-18.7-3.66-3.44
Free Cash Flow Per Share
-0.58-0.72-0.54-0.79-0.70-6.78
Levered Free Cash Flow
-31.25-32.42-24.2-22.23-12.49-6.11
Unlevered Free Cash Flow
-50.13-51.01-48.16-43.02-24.58-17.25
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q